Over 40 years’ heritage
185,800 clients worldwide
Over 15,000 markets

Housebuilders in focus

Tomorrow sees UK housebuilders, Persimmon and Taylor Wimpy, release a trading update. Investors will be keenly awaiting the numbers to assess the outlook for the shares. 

Houses
Source: Bloomberg

Taylor Wimpey suffered in the wake of the Brexit vote, but its shares have recovered since then. March results showed that the firm had a good year overall in 2016, with a 17% rise in revenue, and profits up by over a fifth. A 7% yield and a still cheap valuation at 10 times forward earnings suggest that Taylor Wimpey offers impressive returns over the longer term.

The company has been rising steadily since the November low, and now looks set to head to 211p, the 2016 high. There are no signs that the trend is at an end, with the progression of higher lows and higher highs going back to November. It would need a definitive move below 190p to begin to suggest a more bearish outlook.

Taylor Wimpey chart

Meanwhile, Persimmon has also done well, with 2016 seeing the firm reach the half-way point in its 10-year strategic turnaround plan. Underlying profits rose by 23%, with revenues up by 8%. Both firms benefit from the lack of supply in the housing market, which means that margins remain strong. Demand has not yet abated, thanks to various help to buy schemes from the government. Like Taylor Wimpey, Persimmon boasts a healthy dividend yield and an undemanding forward PE of 10.

The technical picture for Persimmon is similar to Taylor Wimpey, but for the former we have seen all-time highs in the past month. A new breakout above £23.02 would be bullish, while a retracement could see support come in at £22.55 and then £21.58.

Persimmon chart

The information on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG Bank S.A. accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it and as such is considered to be a marketing communication.